Revised. Amendments from Version 1
==================================

We have revised our manuscript to make some small text amendments, in response to Charles Chiu\'s comments.

Background
==========

Metagenomic shotgun sequencing, in which DNA or RNA is extracted from a tissue sample and then sequenced, has the potential to detect a wide range of infections. Deep whole-genome shotgun (WGS) sequencing can detect bacteria, viruses, and eukaryotic pathogens with equal effectiveness, as long as the infectious agent is similar to a species that has been previously sequenced. Sequencing databases already contain thousands of known species, and as this number grows, the sensitivity of WGS will grow as well.

In 2014, a large outbreak of infection with enterovirus D68 was associated with both severe respiratory illness and acute paralysis, which the U.S. Centers for Disease Control and Prevention (CDC) named acute flaccid myelitis (AFM) ^[@ref-1]^. Samples collected from 48 patients were sequenced and shown to form a novel strain, Clade B1, based on phylogenetic analysis of 180 complete enterovirus D68 sequences ^[@ref-2]^. The same study conducted metagenomic sequencing of cerebrospinal fluid (CSF) and/or nasopharyngeal (NP) swabs from 22 of these patients and found enterovirus D68 in some NP samples that were positive based on PCR testing.

The identification of species from a WGS sample is a challenging problem that has spurred the development of multiple new computational methods ^[@ref-3]--\ [@ref-5]^. Because of the large size of next-generation sequencing data sets, these methods need to be very fast, but in the context of clinical diagnosis, they also need to be accurate. We downloaded the 31 next-generation sequencing (NGS) samples from the Greninger *et al*. ^[@ref-2]^ study (NCBI accession SRP055445) and re-analyzed them using a computational pipeline based on the recently developed Kraken metagenomic analysis software ^[@ref-4]^, a very fast and sensitive system that can be customized to use a database containing any species whose sequences are available.

Alternative infectious diagnoses in two subjects
================================================

Among the 22 subjects for which NGS data were available, we found at least two that had far greater numbers of sequences (reads) from a bacterial pathogen than from enterovirus D68. Neither subject had been reported in [@ref-2] as having a bacterial infection.

In one subject, US/CA/09-871, reported by Greninger *et al*. ^[@ref-2]^ as positive for enterovirus D68 through PCR and metagenomic NGS, we found in the NP swab sample an overwhelming presence of bacterial sequences from *Haemophilus influenzae*, a known cause of meningitis and neurological complications that was a common infection prior to the development of an effective vaccine.

Specifically, we identified 2,389,621 reads from *H. influenzae* in this subject, with the closest similarity to strain R2846. These reads comprise 93% of all microbial reads identified at the species level in the sample. Greninger *et al*. ^[@ref-2]^ reported 2,742 reads (in their Supplementary Table 4) matching enterovirus D68 ^[@ref-2]^ but did not report finding any *H. influenzae* reads from this sample. Our analysis found 1,330 reads matching enterovirus D68.

To confirm the identity of these reads, we aligned them separately to the complete genome of *H. influenzae* R2846, and we found that the reads completely covered the genome. Dividing the genome into 100 kilobase windows, depth of coverage varied from 266--828 reads/100Kbp, with far deeper coverage as expected at the 16S ribosomal RNA genes.

The enterovirus D68 isolated from patient US/CA/09-871 differed from the others in that it appeared in 2009, well before the 2014 outbreak, and that it grouped with Clade C, phylogenetically distinct from Clade B1 that was associated with AFM. This patient was reported ^[@ref-2]^ as having respiratory illness but not AFM. The sequence evidence here suggests that the patient might have had complications from *H. influenzae*-associated infection, although no clinical or CSF data was available for our re-analysis.

In a second subject, US/CA/12-5837, we found a strikingly large number of reads from *Staphylococcus aureus* in the NP swabs. The two separate NGS files associated with this subject contained 6,858,453 and 1,343,806 reads, comprising 70% and 84% (respectively) of all non-human reads identified at the species level in each sample. The closest match was *S. aureus* subsp. *aureus* MRSA252, a methicillin-resistant strain. The coverage was deep enough, approximately 40X, that it would be possible to assemble this genome separately from the reads here ( [Figure 1](#f1){ref-type="fig"}). Greninger *et al*. ^[@ref-2]^ reported 2,790 reads from enterovirus D68 in this subject (our analysis found 1,641) but did not report any from *S. aureus*.

![Depth of read coverage of the *S. aureus* MRSA252 genome using reads identified in the NGS sample from subject US/CA/12-5837.\
High peaks correspond to 16S rRNA genes. Red line: median coverage; blue line: mean coverage.](f1000research-4-7307-g0000){#f1}

Patient US/CA/12-5837 was sampled in 2012, two years before the outbreak of AFM, although this patient was described in Greninger *et al*. ^[@ref-2]^ as positive for enterovirus D68 based on clinical PCR testing and metagenomic sequencing. This patient is reported to be one of the first patients with enterovirus-D68-positive AFM ^[@ref-2]^, but the sequence evidence indicates a severe *S. aureus* infection that might explain at least some of the patient's symptoms. *S. aureus* has been implicated in neurological complications such as myelitis ^[@ref-6]^ and meningitis ^[@ref-7]^ by mechanisms that involve not only direct invasion into the central nervous system (CNS), but also immunopathogenic responses triggered by superantigens that can target the CNS ^[@ref-8]^. At a minimum, *S. aureus* infection was overlooked by the previous analysis. Although the potential role of bacterial infection in the neurological disease that affected these two subjects is difficult to assess because of the lack of clinical and CSF information, its involvement as a pathogenic co-factor should be evaluated.

Human reads included in database submission
===========================================

The metagenomics data (NCBI accession SRP055445) released by Greninger *et al*. ^[@ref-2]^ comprise 43 files which cover 22 of the 48 subjects from their study (in their Supplementary Table 1); the study did not conduct NGS for all subjects. Our metagenomics pipeline identifies human reads at the same time that it searches for pathogens; therefore we scanned the data for human as well as microbial content. Greninger *et al*. ^[@ref-2]^ reported that all human sequences had been removed from these files. We found, however, that all samples contained large numbers of human reads, ranging from a low of 18,215 to a high of 6,159,868. These comprised as few as 0.5% to as many as 95.6% of the reads in each sample, as shown in [Table 1](#T1){ref-type="table"}.

###### Human reads found in metagenomic NGS samples from which human sequences were supposed to have been removed.

Shown are the number of reads in each sample that clearly match the human genome and do not match any microbial species. AFM: acute flaccid myelits; NP: nasopharyngeal swap; CSF: cerebrospinal fluid.

  -----------------------------------------------------------
  Isolate         Run ID       Source    Number\     %human
                                         of human\   
                                         reads       
  --------------- ------------ --------- ----------- --------
  US/CA/12-5641   SRR1919640   NP        6,159,868   85.4

  US/CA/12-5641   SRR1919641   NP        1,427,490   90.8

  US/CA/12-5806   SRR1919642   NP        164,876     89.8

  US/CA/12-5806   SRR1919643   CSF       202,677     95.5

  US/CA/12-5807   SRR1919644   NP        160,719     94.1

  US/CA/12-5807   SRR1919645   CSF       383,094     24.2

  US/CA/12-5809   SRR1919646   NP        65,635      95.4

  US/CA/12-5809   SRR1919647   NP        456,228     70.4

  US/CA/12-5837   SRR1919648   NP        4,662,958   20.2

  US/CA/12-5837   SRR1919649   NP        1,251,672   28.6

  US/CA/14-5999   SRR1919650   CSF       3,046,664   89.9

  US/CA/14-5999   SRR1919651   NP        1,407,842   71.0

  US/CA/14-5999   SRR1919933   NP        174,140     68.5

  US/CA/14-6000   SRR1919652   CSF       746,831     91.1

  US/CA/14-6000   SRR1919653   NP        164,638     0.6

  US/CA/14-6000   SRR1919934   NP        19,469      0.5

  US/CA/14-6007   SRR1919654   CSF       352,391     85.4

  US/CA/14-6010   SRR1919655   CSF       426,172     93.2

  US/CA/14-6010   SRR1919656   NP        1,194,587   38.8

  US/CA/14-6010   SRR1919935   NP        144,391     36.7

  US/CA/14-6013   SRR1919657   NP        544,276     87.4

  US/CA/14-6013   SRR1919658   NP        1,636,067   83.9

  US/CA/14-6013   SRR1919936   NP        213,180     79.8

  US/CA/14-6067   SRR1919659   CSF       567,263     3.9

  US/CA/14-6067   SRR1919937   CSF       66,076      2.3

  US/CA/14-6070   SRR1919660   CSF       578,579     4.3

  US/CA/14-6070   SRR1919938   CSF       88,153      3.2

  US/CA/14-6102   SRR1919661   CSF       791,143     82.4

  US/CA/14-6102   SRR1919939   CSF       92,723      78.2

  US/CO/13-60     SRR1919662   CSF       519,456     95.7

  US/CO/13-60     SRR1919940   CSF       79,477      93.4

  US/CO/14-86     SRR1919663   CSF       155,058     38.4

  US/CO/14-86     SRR1919941   CSF       18,215      26.5

  US/CO/14-88     SRR1919664   NP        453,411     3.8

  US/CO/14-88     SRR1919942   CSF       39,899      2.7

  US/CO/14-93     SRR1919665   CSF       758,650     96.6

  US/CO/14-93     SRR1919943   CSF       123,250     95.3

  US/CO/14-94     SRR1919666   NP        835,689     96.1

  US/CO/14-94     SRR1919944   NP        131,998     95.2

  US/CO/14-95     SRR1919667   CSF       352,679     2.8

  US/CA/11-1767   SRR1919639   Culture   1,030,900   33.7

  US/CA/10-786    SRR1919638   NP        130,044     0.5

  US/CA/09-871    SRR1919637   CSF       384,285     11.0
  -----------------------------------------------------------

The inclusion of human sequence data in the files deposited at NCBI was likely a result of a computational method (SURPI ^[@ref-5]^) that was insufficiently sensitive. Although the exact cause cannot be determined here, it is well known that sequence alignment algorithms often trade speed for sensitivity; e.g., by allowing fewer mismatches, an aligner can process reads at a much higher rate, at the cost of missing some alignments. It is less clear why the very large numbers of matches to two bacteria were missed; for both these bacteria, complete genomes from multiple strains are available in GenBank. We used both the Kraken system ^[@ref-4]^ and the Bowtie2 aligner ^[@ref-9]^ to ensure both sensitivity and speed in our analysis.

Release of sequence data is highly valuable, if not essential, for reproducibility and validation of sequencing-based studies. Failure to filter human reads from a sample is not uncommon; a recent study ^[@ref-10]^ found that Human Microbiome Project samples, from which human DNA was supposed to have been removed, contain up to 95% human sequence. This suggests that future efforts to deposit microbiome data need to employ more sensitive computational screens in order to avoid the unintentional release of human sequence data.

Methods
=======

Sequences were extracted from SRP055445 and each file was separately run through the Kraken program version 0.10.6-beta ( <https://github.com/DerrickWood/kraken>) ^[@ref-4]^, which identifies species by comparison with a database of all 31-bp sequences in all species. The database included the human genome (version GRCh38.p2), all complete bacterial and viral genomes, selected fungal pathogens, and known laboratory vector sequences from the NCBI UniVec database ( <http://www.ncbi.nlm.nih.gov/tools/vecscreen/univec>). Percentages of bacterial and viral reads in each sample were re-computed after excluding human and vector sequences. Reads matching more than one species were classified at the genus level or above. Reads from *H. influenzae* and *S. aureus* were re-aligned using Bowtie2 version 2.2.5 ^[@ref-9]^, a very fast and sensitive program for alignment of NGS reads to a reference genome, with the \--local option. Bowtie2 was also used to re-align all reads from US/CA/12-5837 and US/CA/09-871 to the sequence of multiple enterovirus D68 strains (GenBank accessions JX101846.1, AY426531.1, KM851231.1, KM892500.1, KM892501.1, KM881710.2, KP745751.1, KP745755.1, KP745757.1, KP745760.1, KP745764.1, KP745766.1, and KP745767.1). We report the highest number of reads matching any one of these strains.
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